Forbes explores TELI’s rigorous approach to longevity medicine
Plus: Elysium launches Balance for menopause, NewBeauty picks Creatine+ for women, and celebrity esthetician Kristyn Smith’s Elysium routine.
Elysium Newsletter <[email protected]>
Share
Elysium Health promotes its new product Balance, a longevity-based approach to menopause relief. The company also highlights recent media coverage, including a Forbes feature on its rigorous approach to longevity medicine. Elysium Health showcases Balance as a first-of-its-kind solution for menopause symptoms and long-term health.
What the raw message shows
From the headers
- Sent with
-
Klaviyo See it in the headers
In the HTML
- Built with
- Dark-mode styles
Across Elysium Health's email
- Sends
- About 2 a week
- DMARC
-
Enforced, quarantine
Mail failing authentication goes to spam.
The copy
596 words · about 3 min to read · 2 buttons
Thank you for reading our October newsletter. This month’s edition is 1,011 words, about a 4-minute read.
Want to get the Elysium Newsletter in your inbox? Sign up here.
October 2026
Volume 10, Issue 10
Earlier this month, we were proud to introduce Balance, an entirely new approach to menopause that offers relief for symptoms today and support for healthy aging in the years to come. Beyond our latest product launch, Forbes took a deep dive into The Elysium Longevity Institute, exploring our first step toward setting a new standard for personalized longevity care. The Cut spotlighted celebrity esthetician Kristyn Smith’s daily routine, which features multiple Elysium products, while NewBeauty explored creatine’s growing relevance for women and highlighted Creatine+. Plus, The New York Post and Town & Country featured Elysium in recent shopping guides.
Meet Balance: A first-of-its-kind approach to menopause, grounded in longevity science
Balance was developed with a broader view of menopause: to provide targeted symptom relief during this significant phase of life while supporting long-term health for the vibrant decades ahead.
“Menopause is much more than a collection of symptoms—it is a whole-body biological transition that influences women's health for decades,” said Elysium VP of Product Development Lynne Chang, Ph.D. “We developed Balance to reflect that reality.”
Balance combines NR+PT (nicotinamide riboside and pterostilbene), clinically proven by Elysium to increase NAD+ levels and newly studied for menopausal symptom support, with S-equol, clinically studied for hot flash relief and healthy bone markers, and ergothioneine, a potent cellular antioxidant that helps protect against oxidative stress. In a recently published Elysium pilot study, participants taking NR+PT reported improvements in hot flashes, poor sleep, and bloating.†
Button Discover Balance
†Self-reported results from studies of individual ingredients. Changes may reflect factors unrelated to NR+PT, such as diet, physical activity, and lifestyle choices.
Forbes explores TELI—and the science-first philosophy behind Elysium's next chapter
Forbes | GHK-cu | Sermorelin | Glutathione
For more than a decade, Elysium has been guided by the belief that “aging science could leave the lab without leaving its standards behind.” In a new feature, Forbes tells the story of our most ambitious expansion since launching the company in 2015—The Elysium Longevity Institute (TELI). TELI is Elysium’s “move from being the serious NAD+ company to being the company that decides which longevity tools deserve a physician’s name on the order,” says contributor Tanya Akim. “That is a much harder business than selling Basis supplements. It is also the one the field keeps saying it wants.” Akim starts in Guarente’s lab at MIT, where they “helped define modern sirtuin and NAD+ biology.” Comparing Elysium to other emerging brands in the rapidly evolving field of longevity medicine, she notes that “Elysium has a more credible scientific origin story than most entrants,” and highlights the foundational elements of TELI and the vision for its future that will further set it apart. “A research program that reports who improves, who does not, and what gets discontinued would be a standard.”
Button Read the full story in Forbes
THE CUT spotlights a celebrity esthetician’s daily Elysium routine
Celebrity esthetician Kristyn Smith knows what it takes to meet the standards of some of the world’s most discerning beauty clients. In a recent feature for The Cut, she shared a look at her daily routine, including four Elysium supplements she takes every day. “For supplements, I take Mosaic (hyaluronic acid and collagen), Basis (NAD+), Matter ([Oxford-studied tri-vitamin complex] + omega-3s), and Cofactor (collagen peptides) from Elysium,” she said. When your work revolves around knowing the best in beauty, what you choose for yourself carries weight.
The words as text: what a screen reader can follow, and all there is when images don't load.
What the headers say
Read from the message's own headers, as it arrived.
- Came from
-
o1316.shared.klaviyomail.com
· 167.89.100.85
Klaviyo's sending servers
- SPF
- Pass for send.elysiumhealth.com
- DKIM
-
- Pass signed by elysiumhealth.com
- DMARC
-
Pass for elysiumhealth.com
Policy: quarantine
- Unsubscribe
-
One-click
Meets the Gmail and Yahoo rule for bulk senders.
- Complaints
- No feedback-loop header
Show all 21 headers Hide the headers
As received, minus the delivery side: the archive's own addresses show as [recipient], its mail servers as [receiver], signatures are left out and unsubscribe links trimmed to their host.
Route
- Received Identifies Klaviyo
- from o1316.shared.klaviyomail.com (167.89.100.85) by [receiver] (cloudflare) id lX3t4ZjF4C4a for <[recipient]>; Sun, 25 Oct 2026 12:15:34 +0000
- Received
- by recvd-d595d5f8b-xc7zg with SMTP id recvd-d595d5f8b-xc7zg-1-6ADDF2E6-57 2026-10-25 12:15:34.181168256 +0000 UTC m=+2229314.419219054
- Received
- from MjAwMDcxNDM (unknown) by geopod-ismtpd-18 (SG) with HTTP id fX4ZCa4OQlGTt-tkZabKOg Sun, 25 Oct 2026 12:15:34.177 +0000 (UTC)
Authentication
- Received-SPF Authentication result
- pass ([receiver]: domain of [recipient]@send.elysiumhealth.com designates 167.89.100.85 as permitted sender) receiver=[receiver]; client-ip=167.89.100.85; envelope-from="[recipient]@send.elysiumhealth.com"; helo=o1316.shared.klaviyomail.com;
- Authentication-Results Authentication result
- [receiver]; dkim=pass header.d=elysiumhealth.com header.s=kl2 header.b=s1zjFeeN; dmarc=pass header.from=elysiumhealth.com policy.dmarc=quarantine; spf=none ([receiver]: no SPF records found for [email protected]) smtp.helo=o1316.shared.klaviyomail.com; spf=pass ([receiver]: domain of [recipient]@send.elysiumhealth.com designates 167.89.100.85 as permitted sender) smtp.mailfrom=[recipient]@send.elysiumhealth.com; arc=none smtp.remote-ip=167.89.100.85
Platform
- X-Kmail-Account
- R8xQKv
- X-Kmail-Message
- 01M5QP2PMXZ449VCBMD0SYZTTP
- X-Kmail-Ops
- 01KX28G5HSKQA9CNV085MJW4AC
- X-SG-EID
- u001.Xv32TvI6iuV+tZ4vlqHO3FesVXhKuLs/35vTDiHBGEoe78YqTYKTrjCY1Ecr8LbUFtuxQpd9gm/JrHgphOlryJ3qFPgfPv0wiehcrvgC3G4x6eFZvhz/S/onebAIamjKvOe6REPVkZLgc225R5HVBlM64IHmOfxZKrpRpQmY4ZUzNf/nUrrQhCwmFq9Yn/KyXWVDL/AR83N8AkTvppYwi+3qElJoDZp0PlXfL6zjQCbdr1RVvnf20x4W9ARPkiQi
- X-SG-ID
- u001.SdBcvi+Evd/bQef8eZF3BiU3Zi1S53GtqGa3TWBmqe75yn5aYrkvkfG+ZGKrHRvqHEqNnYhXzKEMbIPUuNbUdfpjphyJI24ahdp5cMyD+gtd10HMsYQGG+9KCgoFZ++5EVWromru2FKCazsy6XMElojZhcrjPNxJ2qdL11GQ7vOG5gZAdE1Pp5hajYRpS6iqXBXGHhgOVVx6EjxKNS6btZhGJrHsZzUGKUAqpLgNm4WPv6r5emvXvMC4OGKBKEoj1IvLeZM9/HjaIXWcx26Q/bC814Tp6aqR/PoQDAddof1E+6llMcRL9kxsSlNGVPs8Eh5o7D6rOXWt1Cvtj0ZJS/0feUcCyBSndnMGkh2AvxySHoz+dvqJaKFx69JyP4eKJRA+gBwMpIFHdLFKztEGNA==
- X-Entity-ID
- u001.lP8bpbcNOc7n5/pI/ei+9g==
Unsubscribe and feedback
- List-Unsubscribe
- <https://manage.kmail-lists.com/…>
- List-Unsubscribe-Post
- List-Unsubscribe=One-Click
- X-Report-Abuse
- Please report any spam or abuse to: [email protected]
Message
- Content-Type
- multipart/alternative; boundary=57a3c2fb909b8682ef0475f217987b3a9f860fb00a81fda962ab1df158da
- Date
- Sun, 25 Oct 2026 12:15:34 +0000 (UTC)
- From
- Elysium Newsletter <[email protected]>
- Mime-Version
- 1.0
- Message-ID
- <fX4ZCa4OQlGTt-tkZabKOg@geopod-ismtpd-18>
- Subject
- Forbes explores TELI’s rigorous approach to longevity medicine
- Reply-To
- [email protected]
More from Elysium Health
All 34 emailsSimilar campaigns from other brands
Different brands running the same play. Compare any of them side by side.
Archived for reference and commentary. Elysium Health, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.